C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/14/2002	WO2002090545A2 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide
11/14/2002	WO2002090544A2 Protein-protein interactions in adipocyte cells (3)
11/14/2002	WO2002090543A2 Regulation of human phosphatidic acid phosphatase type 2c-like protein
11/14/2002	WO2002090542A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof
11/14/2002	WO2002090541A1 Determination of a genetic predisposition for behavioural disorders
11/14/2002	WO2002090540A1 Ethylene insensitive plants
11/14/2002	WO2002090539A2 Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
11/14/2002	WO2002090537A1 Process for synthesizing protein using cell-free protein synthesis system
11/14/2002	WO2002090536A2 A method for producing recombined polynucleotides
11/14/2002	WO2002090535A1 Methods and compositions comprising renilla gfp
11/14/2002	WO2002090533A2 Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
11/14/2002	WO2002090532A1 Novel mutation
11/14/2002	WO2002090531A2 Peptidylarginine deiminase 6
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002090529A1 Dna molecules encoding macaca mulatta androgen receptor
11/14/2002	WO2002090524A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002	WO2002090523A2 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid
11/14/2002	WO2002090522A2 Use of phosphorothiolate polynucleotides in ligating nucleic acids
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090517A2 Novel human kinases and polynucleotides encoding the same
11/14/2002	WO2002090516A2 Design of artificial genes for use as controls in gene expression analysis systems
11/14/2002	WO2002090514A2 Epidermal growth factor receptorantisense oligonucleotides
11/14/2002	WO2002090509A2 Materials and methods for producing tomato yellow leaf curl virus resistance in plants
11/14/2002	WO2002090507A2 Oligonucleotide inhibitors of cancer cell proliferation
11/14/2002	WO2002090506A2 Metabolite transporters
11/14/2002	WO2002090504A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	WO2002090501A2 Vectors having replication, immunogenicity and/or pathogenicity under stress promoter regulation and use thereof
11/14/2002	WO2002090499A2 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/14/2002	WO2002090498A2 A high throughput assay for identification of gene expression modifiers
11/14/2002	WO2002090497A2 Transgenic high tryptophan plants
11/14/2002	WO2002090496A2 Novel methods of directed evolution
11/14/2002	WO2002090495A2 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
11/14/2002	WO2002090493A2 Δ4-desaturase genes and uses thereof
11/14/2002	WO2002090492A2 Fungal chitinases, polynucleotide sequences encoding same, promoters of same, and uses thereof
11/14/2002	WO2002090491A2 Modification of metal-handling in plants
11/14/2002	WO2002090443A1 Synthesis and evaluation of new cyanine dyes as minor groove of [poly(da-dt)]2 binders
11/14/2002	WO2002090388A1 Derivatives of exendin
11/14/2002	WO2002090386A2 Regulatory protein involved in pectin modification
11/14/2002	WO2002090383A2 M. catarrhalis antigens
11/14/2002	WO2002090378A2 Haplotypes of the ces2 gene
11/14/2002	WO2002090377A2 Peptides that bind to dna and inhibit dna replication, and methods of use
11/14/2002	WO2002090372A2 Products containing charged biomaterials and method for the preparation thereof
11/14/2002	WO2002090371A2 Method for preparative production of long nucleic acids by pcr
11/14/2002	WO2002090319A1 Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules
11/14/2002	WO2002090300A2 Nucleic acids and proteins with thioredoxin reductase activity
11/14/2002	WO2002089973A2 Affinity reaction probe detection/analysis chips and detection system and apparatus using the same
11/14/2002	WO2002089857A2 Trans-viral vector mediated gene transfer to the retina
11/14/2002	WO2002089856A1 Techniques and compositions for treating cardiovascular disease by (in vivo) gene delivery
11/14/2002	WO2002089840A1 Recombinant bicistronic flaviviruses and methods of use thereof
11/14/2002	WO2002089831A1 Preventives/remedies for nephritis
11/14/2002	WO2002089817A2 Anti-virus agent
11/14/2002	WO2002089747A2 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	WO2002089728A2 Recombinant rhabdoviruses as live-viral vaccines
11/14/2002	WO2002089657A2 Diagnostic markers of acute coronary syndromes and methods of use thereof
11/14/2002	WO2002089586A1 Lung epithelial cell line for propagating viruses
11/14/2002	WO2002089567A2 Sca2 knockout animal and methods of use
11/14/2002	WO2002089561A1 Tyra genes and uses thereof
11/14/2002	WO2002089555A2 Methods and compositions to modulate ethylene sensitivity
11/14/2002	WO2002081694A8 Method for the sectetion and production of protein
11/14/2002	WO2002079393A9 Dynamic action reference tools
11/14/2002	WO2002077159A3 End group activated polymers with oligonucleotide ligands
11/14/2002	WO2002074948A3 Animal tissue with carbohydrate antigens compatible for human transplantation
11/14/2002	WO2002074904A3 Rearranged squamous cell carcinoma antigen genes ii
11/14/2002	WO2002074326A3 Urocortin-iii and uses thereof
11/14/2002	WO2002072605A3 Expression technology for proteins containing a hybrid isotype antibody moiety
11/14/2002	WO2002072603A3 Novel human dectin proteins and polynucleotides encoding the same
11/14/2002	WO2002068667A3 Regulatory elements from rp1 gene and uses thereof
11/14/2002	WO2002066628A3 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
11/14/2002	WO2002064745A3 Transformation and regeneration of sunflower from cotyledons
11/14/2002	WO2002061081A9 A novel gene bn01 mapping to chromosome 16q24.3
11/14/2002	WO2002060376A3 Induction of tolerance by apoptotic and/or necrotic cells
11/14/2002	WO2002056918A3 Method of enhancing delivery of a therapeutic nucleic acid
11/14/2002	WO2002053713A3 Cloning of a human sulfotransferase
11/14/2002	WO2002053704A3 Protein-protein interactions
11/14/2002	WO2002050252A3 Method for generating competent or transformed cells
11/14/2002	WO2002049422A3 Non-human animal disease models
11/14/2002	WO2002048325A3 Regulation of human serine palmitoyltransferase
11/14/2002	WO2002046455A3 Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use
11/14/2002	WO2002046215A3 Basb221 polypeptides and polynucleotides encoding basb221 polypeptides
11/14/2002	WO2002036797A3 Process for the fermentative preparation of l-amino acids using strains of the enterobacteriaceae family
11/14/2002	WO2002032944A3 Basb208 nucleotide and amino acid sequences from haemophilus influenzae
11/14/2002	WO2002029048A3 Regulation of human sodium-dependent neurotransmitter transporter
11/14/2002	WO2002028906A3 Regulation of human sphingosine kinase-like protein
11/14/2002	WO2002016440A8 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections
11/14/2002	WO2002011530A9 Transgenic animal
11/14/2002	WO2001062984A3 Detection of human papilloma viruses
11/14/2002	WO2001048244A3 Detection of single nucleotide polymorphisms
11/14/2002	WO2001036659A3 Selectable cell surface marker genes
11/14/2002	WO2001031036A9 Modified viral surface proteins which bind to cells of tumor vasculature
11/14/2002	WO2001029179A3 Regulation of gene expression by neuromodulators
11/14/2002	WO2001019842A9 Subunit optimized fusion proteins
11/14/2002	US20020170096 Genetically engineered soybean cell for use as expression tool in plant genetic engineering
11/14/2002	US20020170095 Nucleotide sequences coding polypeptide for use in controlling plant propagation and gene expression
11/14/2002	US20020170094 Nucleotide sequences coding polypeptide for use in generating disease resistant plants
11/14/2002	US20020170093 Nucleotide sequences coding polypeptide for use in the generation of preferential phenotype in plants
11/14/2002	US20020170092 Modification of polysaccharides
11/14/2002	US20020170091 Acyl CoA:cholesterol acyltransferase related nucleic acid sequences
11/14/2002	US20020170090 Cell for use in the generation of prefrential plant enzymatic polypeptide
11/14/2002	US20020170089 Nucleic acids encoding defense inducible proteins and uses thereof
11/14/2002	US20020170088 Nucleotide sequences coding polypeptide for use in propagation control in plants

1 ... 2660 2661 2662 2663 2664 2665 2666 2667 2668 2669 2670 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 ... 4023